Gala­pa­gos chops in­to their pipeline, drop­ping core fields and re­or­ga­niz­ing R&D as the BD team hunts for some­thing ...

5 years ago
R&D

With no up­front pay­ment or mile­stones on the line, Nkar­ta and CRISPR join forces on CAR-NK search

5 years ago
Deals
R&D

Q&A: Ain­drea Camp­bell goes small, step­ping away from Ap­ple to head man­u­fac­tur­ing at Zymer­gen — where am­bi­tions are ...

5 years ago
People
Outsourcing

Gold­man Sachs jumps aboard Bain-backed 503(b) com­pound­ing phar­ma­cy with a $275M debt loan to sup­ply hos­pi­tals

5 years ago
Financing
Outsourcing

Lon­za keeps adding on as it looks to beef up bi­o­log­ics of­fer­ing, tack­ing on near­ly $1B in ex­pan­sions in EU, US

5 years ago
Outsourcing
Manufacturing

An­oth­er Mod­er­na ex­pan­sion is an­nounced, this time at its Mass­a­chu­setts site

5 years ago
Manufacturing

Catal­ent snaps up Promether­a's cell ther­a­py sub­sidiary, com­plete with a Bel­gian plant to help scale plas­mid DNA ...

5 years ago
Outsourcing
Manufacturing

Keytru­da gets ac­cel­er­at­ed OK in HER2-pos­i­tive gas­tric can­cer; Twin­Strand gets $50M to hunt for 'nee­dles in a ...

5 years ago
News Briefing

Jasper and its stem cell con­di­tion­ing an­ti­body earn a tick­et to Nas­daq in lat­est SPAC re­verse merg­er

5 years ago
Financing

Mod­er­na CEO brush­es off US sup­port for IP waiv­er, eyes more than $19B in Covid-19 vac­cine sales in 2021

5 years ago
Coronavirus
Manufacturing

OcuWho? Star deal­mak­er turned aes­thet­ics czar Brent Saun­ders flips back in­to biotech. But who’s he team­ing up with ...

5 years ago
Startups
Bioregnum

Drug pric­ing watch­dog joins the cho­rus of crit­ics on Bio­gen's ad­u­canum­ab: What about charg­ing $2,560 per year?

5 years ago
Pharma

Covid-19 roundup: Pfiz­er/BioN­Tech do­nate their vac­cine to the Tokyo Olympics; No­vavax, Pfiz­er/BioN­Tech vac­cines ...

5 years ago
Coronavirus

Re­call re­port: Acel­la pulls thy­roid tablets af­ter a raft of side ef­fect re­ports; mis­la­bel­ing caus­es Pfiz­er's Hos­pi­ra ...

5 years ago
FDA+
Manufacturing

The Har­vard sci­en­tist act­ing as ATAI's trea­sure trove launch­es a new psy­che­delics firm fo­cused on drug 'ana­logues'

5 years ago
Financing

Dyno's Er­ic Kel­sic fills the tank in his quest for bet­ter AAV with a group of big-name sup­port­ers on board

5 years ago
Financing
AI

Biden ad­min­is­tra­tion backs a po­lar­iz­ing pro­pos­al to waive IP for all Covid-19 vac­cines

5 years ago
Pharma
FDA+

Tak­ing dou­ble Covid-19 hits, Mer­ck writes off $170M for scrapped drug, high­lights $600M in missed sales

5 years ago
R&D

2sev­en­ty: Nick Leschly brings a trio of top ex­ecs with him on top-speed flight from the blue­bird nest

5 years ago
People

Mod­er­na says Covid-19 vac­cine boost­er in­creased im­mune re­sponse against vari­ants of con­cern

5 years ago
R&D
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Freez­er kits to store vac­cines de­liv­ered to Venezuela; UN chief weighs in on IP ...

5 years ago
Outsourcing
Coronavirus

FDA ex­tends re­search agree­ment with MIT-li­censed or­gan-on-chip sys­tems

5 years ago
Pharma
FDA+

In quest to meet user fee goals, FDA’s per­for­mance con­tin­ues down­ward trend

5 years ago
Pharma
FDA+

Al­ta­sciences, true to its word, ex­pands its foot­print with ac­qui­si­tion of Penn­syl­va­nia CRO

5 years ago
Deals
Manufacturing
First page Previous page 707708709710711712713 Next page Last page
A service from the Financial Times